Expression of prolyl-hydroxylases PHD-1, 2 and 3 and of the asparagine hydroxylase FIH in non-small cell lung cancer relates to an activated HIF pathway

被引:21
作者
Giatromanolaki, Alexandra [1 ,2 ,3 ]
Koukourakis, Michael I. [1 ,2 ,3 ]
Pezzella, Francesco [4 ,5 ]
Turley, Helen [4 ,5 ]
Sivridis, Efthimlos [1 ,2 ,3 ]
Bouros, Demosthenes [1 ,2 ,3 ]
Bougioukas, George [1 ,2 ,3 ]
Harris, Adrian L. [4 ,5 ]
Gatter, Kevin C. [4 ,5 ]
机构
[1] Democritus Univ Thrace, Dept Pathol, Alexandroupolis 68100, Greece
[2] Democritus Univ Thrace, Dept Radiotherapy Oncol, Alexandroupolis 68100, Greece
[3] Democritus Univ Thrace, Dept Pneumol & Thorac Surg, Alexandroupolis 68100, Greece
[4] John Radcliffe Hosp, Canc Res UK Mol Oncol Lab, Inst Mol Med, Oxford OX3 9DU, England
[5] Univ Oxford, Nuffield Dept, Clin Sci Lab, Oxford OX3 9DU, England
关键词
lung cancer; hypoxia inducible factors; prolyl-hydroxylases; asparagine hydroxylases; lactate dehydrogenase;
D O I
10.1016/j.canlet.2007.11.041
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The oxygen sensitive prolyl-hydroxylase domain enzymes (PHDs) and the asparagines hydroxylase (FIH, factor inhibiting HIF) regulate the transcriptional activity of HIFs. We assessed the expression of these enzymes in a series of 73 non-small cell lung carcinomas (NSCLC). A direct association of PHDs with FIH and of the PHDs/FIH with HIFs expression was noted. Thirty three of 73 cases had high HIF/PHD expression, predicting intense HIF activity; 19/73 cases had low H IF and high PHD expression mimicking the normal bronchial pattern-, and 18/73 cases had low HIF/PHD (inactive HIF pathway). High lactate dehydrogenase LDH5 expression was noted in cases with high HIF/PHD phenotype. The value of such a classification in defining different metabolic phenotypes of NSCLC deserves further evaluation. (C) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:87 / 93
页数:7
相关论文
共 19 条
[1]   Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor [J].
Appelhoff, RJ ;
Tian, YM ;
Raval, RR ;
Turley, H ;
Harris, AL ;
Pugh, CW ;
Ratcliffe, PJ ;
Gleadle, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (37) :38458-38465
[2]   Hypoxia-inducible factors and hypoxic cell death in tumour physiology [J].
Bacon, AL ;
Harris, AL .
ANNALS OF MEDICINE, 2004, 36 (07) :530-539
[3]   Exploiting tumour hypoxia in cancer treatment [J].
Brown, JM ;
William, WR .
NATURE REVIEWS CANCER, 2004, 4 (06) :437-447
[4]   Posttranslational hydroxylation of ankyrin repeats in IκB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH) [J].
Cockman, Matthew E. ;
Lancaster, David E. ;
Stolze, Ineke P. ;
Hewitson, Kirsty S. ;
McDonough, Michael A. ;
Coleman, Mathew L. ;
Coles, Charlotte H. ;
Yu, Xiaohong ;
Hay, Ronald T. ;
Ley, Steven C. ;
Pugh, Christopher W. ;
Oldham, Neil J. ;
Masson, Norma ;
Schofield, Christopher J. ;
Ratcliffe, Peter J. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (40) :14767-14772
[5]   The von Hippel Lindau/hypoxia-inducible factor (HIF) pathway regulates the transcription of the HIF-proline hydroxylase genes in response to low oxygen [J].
del Peso, L ;
Castellanos, MC ;
Temes, E ;
Martín-Puig, S ;
Cuevas, Y ;
Olmos, G ;
Landázuri, MO .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (49) :48690-48695
[6]   HYPOXIC REGULATION OF LACTATE-DEHYDROGENASE-A - INTERACTION BETWEEN HYPOXIA-INDUCIBLE FACTOR-1 AND CAMP RESPONSE ELEMENTS [J].
FIRTH, JD ;
EBERT, BL ;
RATCLIFFE, PJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (36) :21021-21027
[7]   Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival [J].
Giatromanolaki, A ;
Koukourakis, MI ;
Sivridis, E ;
Turley, H ;
Talks, K ;
Pezzella, F ;
Gatter, KC ;
Harris, AL .
BRITISH JOURNAL OF CANCER, 2001, 85 (06) :881-890
[8]   Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family [J].
Hewitson, KS ;
McNeill, LA ;
Riordan, MV ;
Tian, YM ;
Bullock, AN ;
Welford, RW ;
Elkins, JM ;
Oldham, NJ ;
Bhattacharya, S ;
Gleadle, JM ;
Ratcliffe, PJ ;
Pugh, CW ;
Schofield, CJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (29) :26351-26355
[9]   Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis [J].
Koukourakis, MI ;
Giatromanolaki, A ;
Sivridis, E ;
Bougioukas, G ;
Didilis, V ;
Gatter, KC ;
Harris, AL .
BRITISH JOURNAL OF CANCER, 2003, 89 (05) :877-885
[10]   Cancer vascularization: Implications in radiotherapy? [J].
Koukourakis, MI ;
Giatromanolaki, A ;
Sivridis, E ;
Fezoulidis, I .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (02) :545-553